Saptak Chem closes trading window from October 1 for Q2FY27 results
- Trading window closed from October 1, 2026, for Q2FY27 results
- Restriction applies to promoters, directors, KMPs, and connected persons
- Window opens 48 hours after result declaration
- Board meeting date for Q2FY27 results to be announced later

*this image is generated using AI for illustrative purposes only.
Saptak Chem and Business Limited has closed its trading window for dealing in company securities starting Thursday, October 1, 2026. This closure precedes the declaration of unaudited financial results for the quarter ended September 30, 2026 (Q2FY27).
The restriction applies to promoters, members of the promoter group, directors, key managerial personnel (KMPs), insiders, designated persons, connected persons, and their immediate relatives. The window will remain closed until 48 hours after the board meeting declares the financial results.
Regulatory Compliance and Restrictions
The decision adheres to Clause 4(2) of Schedule B read with Regulation 9 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. It also complies with SEBI Circular No. SEBI/HO/ISD/ISD-SEC-4/P/CIR/2022/107 dated August 5, 2022, and SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/124 dated July 19, 2023.
All designated persons are advised not to enter into any transaction involving the securities of the company during this period. The company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities by Designated Persons governs these restrictions.
Upcoming Board Meeting
The date of the board meeting for publishing the unaudited financial results for Q2FY27 will be announced in due course. The intimation was submitted to The BSE Limited on September 28, 2026, by Jubin Premji Gada, Director of the company.
Historical Stock Returns for Saptak Chem & Business
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | -39.18% | +214.11% | +465.52% |
How might the upcoming Q2FY27 financial results for Saptak Chem influence its stock valuation relative to current sector benchmarks?
What are the expected capital allocation strategies or dividend announcements likely to be revealed at the pending board meeting?
How will the post-results trading window reopening impact liquidity and price volatility for the company's shares?

































